Lexaria Bioscience Valuation Multiples

Lexaria Bioscience Overview

About Lexaria Bioscience

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Founded

2004

HQ

Employees

7

Website

lexariabioscience.com

Sectors

BiopharmaceuticalsBioTechCannaTechViceTech

Financials (LTM)

Revenue: $267K

Net Income: ($8M)

EV

$20M

Valuation Multiples

Multiples.vc

Start free trial

Lexaria Bioscience Financials

Lexaria Bioscience reported last 12-month revenue of $267K.

In the same LTM period, Lexaria Bioscience generated had net loss of ($8M).

Lexaria Bioscience P&L

In the most recent fiscal year, Lexaria Bioscience reported revenue of $706K and EBITDA of ($12M).

Lexaria Bioscience expects next 12-month revenue of XXX and NTM EBITDA of XXX

Lexaria Bioscience Stock Performance

Lexaria Bioscience has current market cap of $24M, and enterprise value of $20M.

Lexaria Bioscience's stock price is $0.98.

Lexaria Bioscience Valuation Multiples

Lexaria Bioscience trades at 75.3x EV/Revenue multiple, and (1.7x) EV/EBITDA.

Lexaria Bioscience Financial Valuation Multiples

As of April 14, 2026, Lexaria Bioscience has market cap of $24M and EV of $20M.

Equity research analysts estimate Lexaria Bioscience's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Lexaria Bioscience has a P/E ratio of (2.9x).

Lexaria Bioscience Margins & Growth Rates

Lexaria Bioscience's revenue in the last 12 month grew by 226%.

Lexaria Bioscience's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $1.8M for the same period.

Lexaria Bioscience Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Lexaria Bioscience M&A Activity

Lexaria Bioscience acquired XXX companies to date.

Last acquisition by Lexaria Bioscience was on XXXXXXXX, XXXXX. Lexaria Bioscience acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Lexaria Bioscience Investment Activity

Lexaria Bioscience invested in XXX companies to date.

Lexaria Bioscience made its latest investment on XXXXXXXX, XXXXX. Lexaria Bioscience invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).